Therapy of hyperthyroidism in pregnancy and breastfeeding

Obstetrical and Gynecological Survey

Volumn 66, Issue 6, 2011, Pages 378-385

  Fumarola, Angela ^a   Di Fiore, Agnese ^a   Dainelli, Michela ^a   Grani, Giorgio ^a   Carbotta, Giovanni ^a   Calvanese, Anna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; IODIDE; LUGOL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RITUXIMAB; THIAMAZOLE; THIOAMIDE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ACUTE HEPATITIS; AGRANULOCYTOSIS; ANTIBIOTIC PROPHYLAXIS; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; APLASTIC ANEMIA; APNEA; ARTHRALGIA; BRADYCARDIA; BREAST FEEDING; CHOANA ATRESIA; CORDOCENTESIS; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG SAFETY; EMBRYOPATHY; ESOPHAGUS ATRESIA; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS HEART RATE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; FREE THYROXINE INDEX; GOITER; GRANULOCYTOPENIA; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOTHYROIDISM; INTELLIGENCE; LIVER FAILURE; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; LOW DRUG DOSE; NAUSEA; OBSTRUCTIVE JAUNDICE; PHYSICAL DEVELOPMENT; PREGNANCY; PREGNANT WOMAN; PRURITUS; REVIEW; SKIN APLASIA; SMELLING DISORDER; TERATOGENICITY; THYROID CRISIS; THYROID GLAND EXAMINATION; THYROIDECTOMY; URTICARIA; VASCULITIS;

ADRENERGIC BETA-ANTAGONISTS; BREAST FEEDING; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; THIOAMIDES; THYROID CRISIS;

EID: 80052158884     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31822c6388     Document Type: Review

References (65)

1. Abalovich M, Amino N, Barbour LA, et al. Guideline: management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92(suppl 8):S1-S47. (Pubitemid 47236338)
2. Luewan S, Chakkabut P, Tongsong T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet. 2011;283:243-247.
3. Guillaume J, Schussler GC, Goldman J. Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab. 1985;60:678-684. (Pubitemid 15147553)
4. Kamijo K. TSH-receptor antibodies determined by the first, second and third generation assay and thyroid-stimulating antibody in pregnant patients with Graves' disease. Endocr J. 2007;54:619-624. (Pubitemid 47414612)
5. Tan JY, Loh KC, Yeo GS, et al. Transient hyperthyroidism of hyperemesis gravidarum. BJOG. 2002;109:683-688. (Pubitemid 37329281)
6. Matsuura N, Harada S, Ohyama Y, et al. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res. 1997;42:214-218. (Pubitemid 27311343)
7. Mitsuda N, Tamaki H, Amino N, et al. Risk factors for developmental disorders in infants born to women with Grave's disease. Obstet Gynecol. 1992;80:359-364.
8. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab. 2004;18:267-288.
9. Polak M, Leger J, Luton D, et al. Fetal cord blood sampling in the diagnosis and treatment of fetal hyperthyroidism in the offsprings of a euthyroid mother producing thyroid stimulating antibodies. Ann Endocrinol (Paris). 1997;58:338-342. (Pubitemid 27445123)
10. Stoffer SS, Hamburger JI. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med. 1976;17:146-149.
11. Iagaru A, McDougall R. Treatment of thyrotoxicosis. J Nucl Med. 2007;48:379-389. (Pubitemid 47604920)
12. America College of Radiology Standards 1999-2000, ACR standard for the performance of therapy with unsealed radionuclide sources, American College of Radiology, Reston, VA, 1999:265-270.
13. Berg G, Jacobsson L, Nyström E, et al. Consequences of inadvertent radioiodine treatment of Graves' disease and thyroid cancer in undiagnosed pregnancy. Can we rely on routine pregnancy testing? Acta Oncol. 2008;47:145-149.
14. Fumarola A, Di Fiore A, Dainelli M, et al. Medical treatment of hyperthyroidism: state of the art. Exp Clin Endocrinol Diabetes. 2010;118:678-684.
15. Koenig RJ. Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid. 2005;15:835-840. (Pubitemid 41339262)
16. Roy G, Mugesh G. Bioinorganic chemistry in thyroid gland: effect of antithyroid drugs on peroxidase-catalyzed oxidation and iodination reactions. Bioinorg Chem Appl. 2006:23214.
17. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf). 2001;54:365-370. (Pubitemid 32234201)
18. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 1984;20:695-700. (Pubitemid 14105342)
19. Streetman DD, Khanderia U. Diagnosis and treatment of Graves' disease. Ann Pharmacother. 2003;37:1100-1109.
20. Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352:905-917. (Pubitemid 40300299)
21. Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med. 1986;315:24-28. (Pubitemid 16093247)
22. Pearce EN, Braderman LE. Hyperthyroidism: advantages and disadvantages of medical therapy. Surg Clin North Am. 2004; 84:833-847. (Pubitemid 38622420)
23. Nakamura H, Noh JY, Itoh K, et al. Comparison of Methimazole and Propylthiouracil in patient with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab. 2007; 92:2157-2162. (Pubitemid 46997115)
24. Cooper DS. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 2003;88:3474-3481. (Pubitemid 37034479)
25. Cooper DS, Goldminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med. 1983;98:26-29. (Pubitemid 13217959)
26. Bahn RS, Burch HS, Cooper DS, et al. The role of Propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009;19:673-674.
27. Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009;94:1881-1882.
28. Cooper DS. The side-effects of antithyroid drugs. Endocrinologist. 1999;9:457-467.
29. Gunton JE, Stiel J, Clifton-Bligh P, et al. Prevalence of positive antineutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol. 2000;142:587.
30. Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPOANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf). 2001;54:651-654. (Pubitemid 34208909)
31. Van Dijke CP, Heydendael RJ, De Kleine MJ. Methimazole, carbimazole, and congenital skin defects. Ann Intern Med. 1987;106:60-61. (Pubitemid 17228310)
32. Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 1999;83:43-46. (Pubitemid 29104474)
33. Martínez-Frías ML, Cereijo A, Rodríguez-Pinilla E, et al. Methimazole in animal feed and congenital aplasia cutis. Lancet. 1992;339:742-743.
34. Rosenfeld H, Ornoy A, Shechtman S, et al. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol. 2009;68:609-617.
35. Cunningham AR, Carrasquer CA, Mattison DR. A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs. Int J Pediatr Endocrinol. 2009; 2009:936154.
36. Patil-Sisodia K, Mestman JH. Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract. 2010;16:118-129.
37. Ho SS, Metreweli C. Normal fetal thyroid volume. Ultrasound Obstet Gynecol. 1998;11:118-122. (Pubitemid 28175013)
38. Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab. 2005;90:6093-6098. (Pubitemid 41606530)
39. Huel C, Guibourdenche J, Vuillard E, et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol. 2009;33:412-420.
40. Ceccaldi PF, Cohen S, Vuillard E, et al. Correlation between colored Doppler echography of fetal thyroid goiters and histologic study. Fetal Diagn Ther. 2010;27:233-235.
41. Ranzini AC, Ananth CV, Smulian JC, et al. Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med. 2001;20:613-617. (Pubitemid 32499944)
42. Nachum Z, Rakover Y, Weiner E, et al. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol. 2003;189:159-165. (Pubitemid 36886542)
43. Chattaway JM, Pharm D. Propylthiuracil versus methimazole in treatment of Graves' disease during pregnancy. Ann Pharmacother. 2007;41:1018-1022. (Pubitemid 46917629)
44. Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1997;82: 3633-3636. (Pubitemid 27509348)
45. Eisenstein Z, Weiss M, Katz Y, et al. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr. 1992;151:558-559.
46. Kuehn BM. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA. 2009;302:369-371.
47. Gladstone GR, Hordof A, Gersony WM. Propranolol administration during pregnancy: effects on the fetus. J Pediatr. 1975; 86:962-964.
48. Habib A, McCarthy JS. Effects on the neonate of propranolol administered during pregnancy. J Pediatr. 1977;91:808-811. (Pubitemid 8207615)
49. Ferrero S, Colombo BM, Ragni N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet. 2004;269:244-253. (Pubitemid 38661262)
50. El Fassi D, Nielsen CH, Hasselbalch HC, et al. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur J Endocrinol. 2006;154:623-632. (Pubitemid 43810846)
51. Heemstra KA, Toes RE, Sepers J, et al. Rituximab in relapsing Graves' disease, a phase II study. Eur J Endocrinol. 2008;159: 609-615.
52. Salvi M, Vannucchi G, Campi I, et al. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol. 2007;156:33-40. (Pubitemid 46553901)
53. Vinet E, Pineau C, Gordon C, et al. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum. 2009;61:587-592.
54. Pham T, Fautrel B, Gottenberg JE, et al. Rituximab (Mab-Thera) therapy and safety management. Clinical tool guide. Joint Bone Spine. 2008;75(suppl 1):S1-S99.
55. Laurberg P, Bournaud C, Karmisholt J, et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol. 2009;160:1-8.
56. Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989;160: 63-70. (Pubitemid 19055258)
57. Yildizhan R, Kurdoglu M, Adali E, et al. Fetal death due to upper airway compromise complicated by thyroid storm in a mother with uncontrolled Graves' disease: a case report. J Med Case Reports. 2009;3:7297.
58. Gardner DG. Endocrine emergencies. In: Gardner DG, Shoback D, eds. Greenspan's Basic & Clinical Endocrinology. 8th ed. New York: Lange Medical Books, 2007:870-871.
59. Tietgens ST, Leinung MC. Thyroid storm. Med Clin North Am. 1995;79:169-184.
60. Amino N, Tanizawa O, Mori H, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab. 1982;55:108-112. (Pubitemid 13250333)
61. Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 2008;93:3985-3988.
62. Sarathi HA, Bandgar T, Shah NS. Delayed recognition of central hypothyroidism in a neonate born to thyrotoxic mother. Indian Pediatr. 2010;47:795-796.
63. Cooper DS. Antithyroid drugs: to breast-feed or not to breastfeed. Am J Obstet Gynecol. 1987;157:234-235.
64. Azizi F, Bahrainian M, Khamseh ME, et al. Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab. 2003;16:1239-1243. (Pubitemid 38016429)
65. Glatstein MM, Garcia-Bournissen F, Giglio N, et al. Pharmacologic treatment of hyperthyroidism during lactation. Can Fam Physician. 2009;55:797-798.